{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:03:59Z","timestamp":1785416639836,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.04.055","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:31:09Z","timestamp":1778423469000},"page":"982.e1-982.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of MRD Status With Survival Outcomes and Cytokine Release Syndrome in Outpatient Transplantation After Reduced-Intensity Conditioning for Acute Lymphoblastic Leukemia: Experience From a Low- and Middle-Income Country Reference Center"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-9095","authenticated-orcid":false,"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3686-9383","authenticated-orcid":false,"given":"Alberto","family":"Villal\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereida","family":"M\u00e9ndez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Salazar-Riojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Homero","family":"Guti\u00e9rrez-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-3734","authenticated-orcid":false,"given":"Olga Graciela","family":"Cant\u00fa-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.04.055_bib0001","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2026.04.055_bib0002","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.2020007311","article-title":"Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome\u2013negative adult lymphoblastic leukemia","volume":"137","author":"Ribera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.055_bib0003","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41409-018-0373-4","volume":"54","author":"Giebel","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2026.04.055_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400610","article-title":"A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia","volume":"15","author":"Jaime-P\u00e9rez","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.04.055_bib0005","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies","volume":"120","author":"G\u00f6kbuget","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.055_bib0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.14694\/EdBook_AM.2013.33.290","article-title":"Monitoring and managing minimal residual disease in acute lymphoblastic leukemia","author":"Hoelzer","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jtct.2026.04.055_bib0007","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/16078454.2019.1567654","article-title":"Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia","volume":"24","author":"G\u00f6kbuget","year":"2019","journal-title":"Hematology."},{"key":"10.1016\/j.jtct.2026.04.055_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4670-5","article-title":"Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis","volume":"18","author":"Shen","year":"2018","journal-title":"BMC Cancer."},{"key":"10.1016\/j.jtct.2026.04.055_bib0009","article-title":"EuroFlow SOP for bulk lysis in MRD panels version 2.0 [Internet]","year":"2025","journal-title":"EuroFlow"},{"key":"10.1016\/j.jtct.2026.04.055_bib0010","doi-asserted-by":"crossref","first-page":"510.e1","DOI":"10.1016\/j.jtct.2023.05.006","article-title":"Acute leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a Latin American population","volume":"29","author":"Arias-Espinosa","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.04.055_bib0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","article-title":"Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia","volume":"56","author":"Greil","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.055_bib0012","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.bbmt.2020.04.015","article-title":"Long-term outcomes of allogeneic hematopoietic cell transplant with fludarabine and melphalan conditioning and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis in patients with acute lymphoblastic leukemia","volume":"26","author":"Mei","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jtct.2026.04.055_bib0013","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ajh.27701","article-title":"Allogeneic hematopoietic stem cell transplantation for elderly acute lymphoblastic leukemia patients: a registry study from the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et Th\u00e9rapie Cellulaire (SFGM-TC)","volume":"100","author":"Chalandon","year":"2025","journal-title":"Am J Hematol."},{"key":"10.1016\/j.jtct.2026.04.055_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1573334","article-title":"Clinical outcomes and relapse patterns in pediatric acute leukemia patients undergoing hematopoietic cell transplantation: a multicenter Brazilian experience","volume":"13","author":"Pelegrina","year":"2025","journal-title":"Front Pediatr."},{"key":"10.1016\/j.jtct.2026.04.055_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-026-06734-6","article-title":"Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study","volume":"105","author":"Ma","year":"2026","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.04.055_bib0016","article-title":"Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia","author":"Wethmar","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.055_bib0017","doi-asserted-by":"crossref","first-page":"832.e1","DOI":"10.1016\/j.jtct.2025.06.027","article-title":"Outcomes of haploidentical stem cell transplantation for acute lymphoblastic leukemia patients: a single-center experience in Mexico","volume":"31","author":"Jurado","year":"2025","journal-title":"Transplant Cell Ther."},{"key":"10.1016\/j.jtct.2026.04.055_bib0018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/cncr.31874","article-title":"Minimal residual disease\u2013based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia","volume":"125","author":"Yoon","year":"2019","journal-title":"Cancer."},{"key":"10.1016\/j.jtct.2026.04.055_bib0019","first-page":"146","article-title":"Survival of patients with acute leukemia after hematopoietic cell transplantation: 8-years single-center study in Mexico","volume":"23","author":"Ordo\u00f1ez Cuetto","year":"2022","journal-title":"Rev Ecuat Pediatr."},{"key":"10.1016\/j.jtct.2026.04.055_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-91936-7","article-title":"Impact of high-sensitivity flow cytometry on peri-transplant minimal residual disease kinetics in acute leukemia","volume":"15","author":"de Azambuja","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2026.04.055_bib0021","doi-asserted-by":"crossref","first-page":"763.e1","DOI":"10.1016\/j.jtct.2022.07.025","article-title":"Predictive factors and outcomes after allogeneic stem cell transplantation for adults with acute lymphoblastic leukemia in Brazil","volume":"28","author":"Silva","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.04.055_bib0022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.medcli.2024.09.023","article-title":"Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: long follow-up analysis from a single transplant center","volume":"164","author":"Ormazabal V\u00e9lez","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jtct.2026.04.055_bib0023","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/bloodadvances.2018027003","article-title":"The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia","volume":"3","author":"Yeshurun","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.jtct.2026.04.055_bib0024","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.287456","article-title":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","author":"Balduzzi","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.04.055_bib0025","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/CM9.0000000000003150","article-title":"Risk factors for positive post-transplantation measurable residual disease in patients with acute lymphoblastic leukemia","volume":"138","author":"Wang","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jtct.2026.04.055_bib0026","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1182\/bloodadvances.2023009657","article-title":"Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse","volume":"7","author":"Shapiro","year":"2023","journal-title":"Blood Adv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:36:29Z","timestamp":1785414989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726003453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666636726003453"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.055","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of MRD Status With Survival Outcomes and Cytokine Release Syndrome in Outpatient Transplantation After Reduced-Intensity Conditioning for Acute Lymphoblastic Leukemia: Experience From a Low- and Middle-Income Country Reference Center","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}